Scioto Biosciences Company
Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
Industry:
Geroscience
Headquarters:
Indianapolis, Indiana, United States
Zip:
51-100
Founded Date:
2017-01-01
Employees Number:
51-100
Acquisitions Number:
7
Investors Number:
30955000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Series B
Last Funding Type:
Series B
Register and Claim Ownership